Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...

Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) ...

Insulet has secured US Food and Drug Administration (FDA) clearance for an algorithm advancement within its Omnipod 5 ...

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...

Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest ...

Ramon Kataquapit and Michel Koostachin - both from Attawapiskat First Nation - are seeking to intervene in ongoing litigation by nine First Nations challenging the legality of Ontario's Bill 5 ...

Torrey Pines High School. I’ve been living with Type 1 diabetes for over five years, and this weekend, I’ll be attending the ...

December 4, 2025 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the ...

Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...

Around 830 million people globally are living with diabetes, as per WHO. This is a stark reminder that the global diabetes crisis is more serious than ever. For many of us, diabetes immediately brings ...